Find Academic Supervisors

• Adrenal Development
• Reproductive Development
• Transcriptomics
• +10 more

Prof John Achermann is a Clinical Professor of Paediatric Endocrinology at the Genetics & Genomic Medicine Department , University College London (UCL), with an active role at the UCL GOS Institute of Child Health since 2023. His career spans clinical and research expertise in adrenal and sex development , genetic mechanisms of disease , and nuclear receptor biology , highlighted by over 200 publications and an h-index of 67. Education: Bachelor of Arts (Honours), University of Cambridge (1988) Bachelor of Medicine, University of Cambridge (1990) Master of Arts, University of Cambridge (1992) Doctor of Medicine (MD), University of Cambridge (1997) Doctor of Philosophy (PhD), University of Cambridge (2011) His research focuses on molecular genetics of adrenal and reproductive development , integrating transcriptomics and genomic medicine to understand disorders like Turner syndrome, Disorders of Sex Development (DSD), and adrenal insufficiency. Recent work includes single-cell analyses of fetal gonads , exome sequencing for DSD/POI , and NR5A1/SRY regulatory mechanisms . Key awards include the 2025 ESPE Research Award , 2023 Henning Andersen Prize , and 2016 Clinical Endocrinology Trust Lecturer Medal . Scientific Awards: ESPE Research Award (2025) Henning Andersen Prize (2023, 2007) Clinical Endocrinology Trust Lecturer Medal (2016) SPARKS/RCPCH Young Investigator (2007) ESPE Young Investigator (2002) Noble Prize for MD Thesis (1998) As Head of the Molecular Basis of Rare Disease Section and Deputy Head of Genetics & Genomic Medicine at UCL GOS Institute of Child Health, he bridges clinical practice with translational research. He contributes to undergraduate and postgraduate medical education , supervises MSc projects, and serves on the ESPE Local Organising Committee for 2024. His work aligns with UN Sustainable Development Goals for Good Health & Well-Being and Gender Equality .

Ines KrohnView profile

Researcher

• Microbiology
• Biotechnology
• Marine Biotechnology
• +5 more

Dr. Ines Krohn is a Research Group Leader at the University of Hamburg's Faculty of Mathematics, Informatics and Natural Sciences, specifically within the Department of Microbiology & Biotechnology. She leads the "Algae-Bacteria Interactions" research group, focusing on marine and environmental microbiology with biotechnological applications. University of Hamburg (2010-2013): Diploma in Biology University of Hamburg (2013): Dr. rer. nat. in Biology Her research spans two primary areas: 1) Utilizing aquatic and marine resources for biotechnology, particularly through metagenomic analysis of microalgal-bacterial communities to discover novel biomolecules and 2) investigating molecular mechanisms in microalgae-bacteria interactions, including biofilm formation and cell-cell communication. Current projects include MarBioTech (marine biodiversity exploration), AimM (biofilm monitoring), AquaHealth (aquaculture disease prevention), and SuReMetS (marine nutraceuticals for metabolic syndrome). Her publication record demonstrates expertise in metagenomics , biofilm inhibition , microalgal biotechnology , marine enzyme discovery , and antimicrobial applications . Notable collaborations include work with Prof. Wolfgang R. Streit and teams at Hagenbeck Zoo. She actively supervises bachelor's and master's candidates and offers thesis opportunities in metagenomics and biofilm research. Her laboratory explores both fundamental microbial interactions and applied biotechnologies , including biofilm disruption strategies for medical and industrial applications. Specific techniques include RNAseq, functional screening, and enzyme characterization from marine sources.

Frank FriedrichView profile

Researcher

• Insect Morphology
• Phylogenetics
• Evolutionary Biology
• +3 more

Dr. Frank Friedrich is a Researcher at the University of Hamburg , affiliated with the Faculty of Mathematics, Computer Science and Natural Sciences and the Department of Biology . He leads the Electron Microscopy and Morphological Structural Analysis group at the Institute of Animal Cell and Systems Biology . Insect Morphology and Phylogenomics are central to his research Specializes in Synchrotron Radiation Microtomography (SR-μCT) for 3D anatomical reconstructions Collaborates on Holometabola Evolution and Phylogenetic Systematics His work spans Trichoptera (caddisflies) , Mecoptera (scorpionflies) , and Zoraptera , with a focus on head and thoracic anatomy . He has contributed to resolving insect phylogeny through innovative imaging techniques. Publications highlight his expertise in synchrotron radiation-based imaging and larval/adult morphological studies .

Jason MillsView profile

Professor

• Paligenosis
• Cellular Reprogramming
• Stem Cells
• +6 more

Dr. Jason Mills is the Herman Brown Endowed Professor at Baylor College of Medicine, where he serves as Chief of Research and Vice Chief in the Department of Gastroenterology & Hepatology. He is also Co-Director of the Texas Medical Center Digestive Disease Center and Co-Associate Director for Cancer Research Training and Education at the Dan L Duncan Comprehensive Cancer Center. Dr. Mills leads the Mills Lab, which focuses on cellular reprogramming and cancer mechanisms. Dr. Mills received his AB from Washington University in St. Louis (1989), followed by an MD-PhD from the University of Pennsylvania School of Medicine (1997). He completed his postdoctoral fellowship at Washington University Medical Center (2002). Dr. Mills' research centers on paligenosis, a cellular program he identified that allows mature cells to return to a regenerative state. His work explores how this process contributes to tissue repair but also increases cancer risk through the development of precancerous conditions like metaplasia. Using organoid models derived from patient cancer cells and genetic mouse strains, his lab investigates the molecular mechanisms of cellular plasticity in gastric biology, with implications for cancer prevention and treatment. His research integrates cell biology, metabolism, and translational approaches to understand how cells adapt to stressors. Analysis of Dr. Mills' recent publications reveals a strong focus on the molecular mechanisms of paligenosis and its role in gastric metaplasia and cancer development. His work spans basic cell biology investigations of cellular reprogramming to translational studies using patient-derived organoids. Key themes include the role of transcription factors like SOX9, metabolic regulation of cell fate decisions, and the identification of biomarkers for cancer progression. Dr. Mills has received several prestigious awards, including: Excellence in Research and Leadership Award from Baylor College of Medicine (2022) Top Reviewer for Gastroenterology from the American Gastroenterological Association (2022) Membership Induction to the Association of American Physicians (2022) Research Mentor Award from the AGA Institute Council (2022) Dr. Mills currently mentors several graduate students and postdoctoral researchers in the Mills Lab. His research is supported by multiple NIH grants totaling over $30 million, including R01 grants from NCI and NIDDK focused on mechanisms of paligenosis, metaplasia, and gastric cancer development. These grants support investigations into cellular reprogramming, stem cell differentiation, and therapeutic approaches for precancerous lesions. The Mills Lab maintains a collection of organoids derived from patient cancer cells and utilizes advanced techniques including single-cell RNA sequencing and spatial transcriptomics. The lab collaborates with clinicians at Baylor College of Medicine and across the Texas Medical Center to translate basic findings into clinical applications for personalized cancer treatment.

• Ecological and Evolutionary Genomics
• Speciation
• Ecological Adaptation
• +10 more

Jeffrey Feder is a full Professor in the Department of Biological Sciences at the University of Notre Dame, where he has been a faculty member since 1993 and earned tenure in 2006. He is affiliated with the College of Science and contributes to interdisciplinary initiatives including the Eck Institute for Global Health, the Environmental Change Initiative, Advanced Diagnostics and Therapeutics, and the Integrated Biomedical Sciences graduate program. He also directs GLOBES, an NSF-funded interdisciplinary graduate training program in environment and society. Research Interests: Dr. Feder's research focuses on ecological and evolutionary genomics, particularly the mechanisms of sympatric speciation. His lab studies the apple maggot fly ( Rhagoletis pomonella ) as a model system for real-time speciation driven by host plant shifts. His work integrates genomics, population genetics, neurophysiology, and field ecology to understand how ecological adaptation leads to reproductive isolation and biodiversity. Additional interests include vector-borne diseases like Chagas disease and the coevolution of insect communities under climate change. Recent Research Trends: His recent publications highlight the genomic architecture of speciation, the predictability of evolutionary trajectories, and cascading diversification across trophic levels. Articles span topics from transcriptomic responses to host environments to the dynamics of tipping points in speciation, reflecting a multidisciplinary approach combining empirical data with theoretical insights. Sloan Foundation Evolutionary Biology Fellow NSF Career Award Fellow, Wissenschaftskolleg zu Berlin Fellow, John J. Reilly Center for Science, Technology, and Values NSF Dimensions of Biodiversity Grant (co-PI, $2M) Advising and Grants: Dr. Feder has mentored numerous PhD and master’s students, including Cheyenne Tait, Glen Hood, Mary Glover, and Meredith Doellman, many of whom have published high-impact research. He actively recruits graduate students with backgrounds in bioinformatics and evolutionary biology. His lab has secured major funding from the NSF, Indiana Clinical and Translational Science Institute, and other sources to support research on speciation genomics and disease vector diagnostics. Labs and Teams: The Feder Lab at Notre Dame is a vibrant research group focused on evolutionary genetics and genomics. It collaborates widely, including with researchers at the University of Florida, University of Colorado Denver, and Binghamton University. The lab emphasizes both field and laboratory work, maintaining strong ties to the broader Rhagoletis research community and contributing to global understanding of speciation dynamics.

• Biochemistry
• RNA Structure
• Structural Biology
• +6 more

Jessica Brown is an Associate Professor in the Department of Chemistry and Biochemistry at the University of Notre Dame, where she leads a research group focused on RNA structure and function. Her lab investigates the structural, biochemical, and cellular roles of RNA triple helices, with a particular emphasis on the MALAT1 triple helix and its implications in cancer biology. Education: Ph.D. in Biochemistry, The Ohio State University (2010) B.S. in Chemistry and Biological Sciences, Wright State University (2005) Her research lies at the intersection of biochemistry, structural biology, and molecular oncology. She explores fundamental questions about RNA triple helix formation, stability, protein interactions, and degradation pathways. Using techniques such as X-ray crystallography, cryo-EM, and high-throughput assays, her work aims to uncover the biophysical principles governing RNA triplexes and their regulatory roles in human disease. The recent publications from her lab highlight a strong trend in RNA modification, non-coding RNA structure, and therapeutic targeting of oncogenic RNAs. Her studies span from mechanistic enzymology (e.g., METTL16 kinetics) to disease-associated structural rearrangements in MALAT1, reflecting a multidisciplinary approach that bridges basic science and translational applications. Scientific Awards: NIH Pathway to Independence Award (K99/R00), 2014–2019 American Cancer Society Postdoctoral Fellowship, 2012–2014 OSU Presidential Fellowship, 2010 American Heart Association Predoctoral Fellowship, 2008–2010 Dr. Brown advises graduate students and postdoctoral researchers in her lab, fostering training in cutting-edge biochemical and structural methods. While specific grant details are not listed, her sustained research output and prestigious fellowships indicate active external funding. Her lab is positioned at the forefront of RNA structural biology, with future work likely to expand the understanding of the 'triplexome' and develop tools for targeting stable RNA structures in disease. Labs and Research Teams: The Brown Laboratory at the University of Notre Dame employs a collaborative, interdisciplinary team of researchers using structural, biochemical, and cellular approaches to study RNA triple helices. The lab actively recruits graduate and postdoctoral trainees and contributes to major discussions in RNA biology and epitranscriptomics.

Nora J. BesanskyView profile

Professor

• Genetics & Genomics
• Evolutionary Biology
• Entomology
• +5 more

Nora J. Besansky is the Martin J. Gillen Professor in the Department of Biological Sciences at the University of Notre Dame, where she has been a faculty member since 1997. She leads a research laboratory focused on the evolutionary, ecological, and functional genomics of malaria-transmitting mosquitoes, particularly Anopheles species in Africa. Her research interests span Genetics & Genomics , Evolutionary Biology , Entomology , Ecology , and Infectious Disease . She investigates how genomic variation, chromosomal inversions, and environmental adaptation influence vector behavior, population structure, and malaria transmission dynamics. Her work integrates molecular biology, field ecology, and bioinformatics to advance vector control strategies. Her recent publications reveal a strong focus on Anopheles genomics, species divergence, environmental adaptation (e.g., aridity, salinity, heat), and population structure across Africa. She frequently contributes to high-impact journals such as Nature , Science , and Molecular Ecology , often in collaboration with international consortia like the Anopheles 1000 Genomes Project. Her scientific contributions include editorial leadership and tribute articles recognizing pioneers in vector biology, reflecting her standing in the field. She advises graduate students and leads a dynamic research team at Notre Dame. Her laboratory has received continuous funding for projects on vector genomics, adaptation, and malaria epidemiology. She has held prior research positions at the CDC and Emory University, building a career at the intersection of public health and evolutionary genomics. Her lab operates at the forefront of vector biology, combining cutting-edge genomic technologies with ecological field studies to address one of the world’s most persistent infectious disease challenges—malaria.

Geoffrey BartonView profile

Professor

• Bioinformatics
• Computational Biology
• Protein Structure Prediction
• +4 more

Professor Geoffrey Barton is the Chair of Bioinformatics at the Computational Biology department within the School of Life Sciences at the University of Dundee . With a career spanning decades, he has been pivotal in advancing bioinformatics tools and methodologies for analyzing biological data, particularly in protein structure prediction and RNA sequencing. Core Research Interests : Protein structure and function prediction, computational methods for large biological datasets, small RNA analysis, and integration with wet-lab collaborations across plants, model organisms, and human disease. Awards : Fellow of the Royal Society of Edinburgh (2019) Fellow of the Royal Society of Biology (2011) Brian Cox Prize for Excellence in Public Engagement with Research (2023) Publications and Software : He leads the development of widely used tools like JPred (25,000+ predictions/month) and Jalview (55,000+ installations). His group's work spans proteomics, transcriptomics, and structural genomics, addressing questions in basic science and clinical applications. Media and Collaboration : Available for media commentary on bioinformatics and computational biology, he collaborates extensively with international institutions, including the University of Cambridge and Oxford.

Dietmar SchlosserView profile

Researcher

• Environmental Biotechnology
• Microbial Ecology
• Fungal Biotechnology
• +5 more

Dr. Dietmar Schlosser is a Group Leader in Environmental Mycology at the Department of Applied Microbial Ecology within the Helmholtz Center for Environmental Research - UFZ since 2005. His research program focuses on fungal biodegradation of environmental pollutants, particularly synthetic polymers, micro-pollutants, and recalcitrant organic compounds. Education : Diploma in Biology (1990), Friedrich Schiller University Jena PhD in Technical Microbiology (1993), Friedrich Schiller University Jena His research integrates ecological principles with applied biotechnology , emphasizing fungal biochemistry, physiology, and enzymology. Key projects include: TapNature (2021-2027): Exploiting natural fungal systems for bioeconomy FINEST Microplastics (2022-2027): Sustainable materials management PUreValue (2024-2027): Polyurethane biodegradation for upcycling CLEANER (2023-2026): Water cycle resilience in cities Article trends reveal expertise in mycoremediation , lignocellulose valorization , and fungal attack on synthetic polymers , with recent work spanning environmental engineering, microbiology, and biochemical monitoring techniques. He maintains active collaborations with institutions across Europe and contributes to sustainable technology development through his leadership in Environmental Mycology .

Patricia C. LopesView profile

Associate Professor

• Animal Behavior
• Sociality
• Physiology
• +9 more

Dr. Patricia C. Lopes is an Associate Professor at Schmid College of Science and Technology, Chapman University. Her research focuses on animal social behavior, disease transmission, and neuroendocrinology, integrating molecular, physiological, and social dynamics. She employs RFID tracking and behavioral sensors in field and lab experiments to study sickness behaviors and their evolutionary implications. Education: Ph.D. from University of California, Berkeley. Labs: Runs the Lopes Lab, investigating social decision-making networks and infection responses in wild house mice ( Mus musculus domesticus ). Research Highlights: Challenges the kin protection hypothesis for sickness behaviors through experiments on wild and lab mice. Demonstrates that social isolation alters neural transcriptomes and affects disease spread dynamics. Explores maternal physiological responses to infection risks and integrates ecoimmunology with disease ecology frameworks. Key Collaborations: Works with institutions like ETH Zurich, University of Bern, and University of Zurich. Collaborates with experts in behavioral ecology (Barbara König), neurogenomics (Suzy C. P. Renn), and disease dynamics (Greg Albery).

Darshana M. DadhaniaView profile

Associate Professor

• Transplantation Medicine
• Nephrology
• Kidney Transplantation
• +10 more

Darshana M. Dadhania, M.D., M.S., D(ABHI), is an Associate Professor of Medicine at Weill Cornell Medical College and an Associate Attending Physician at NewYork-Presbyterian Hospital. She serves as Medical Director of the Kidney and Pancreas Transplant Program and Program Director of the Transplant Nephrology Fellowship. Additionally, she is Director of the Genomics Division and Associate Director of the Immunogenetics and Transplantation Center. Education: M.D. from University of Medicine and Dentistry of NJ; M.S. in Clinical and Translational Investigation from Weill Cornell; B.A., B.S. from Stevens Institute of Technology. Training: Internal Medicine Residency, Nephrology Fellowship, and Transplant Medicine Fellowship at NewYork-Presbyterian Hospital; additional training in histocompatibility testing. Certifications: Board Certified in Internal Medicine and Nephrology; Diplomate, American Board of Histocompatibility and Immunogenetics. Dr. Dadhania's research focuses on noninvasive biomarkers for kidney allograft outcomes, particularly urinary cell mRNA and cell-free DNA profiling for rejection detection, management of highly sensitized patients, and infectious complications post-transplant. She has pioneered work in gut microbiota interactions with immunosuppression and infection risk. Her studies integrate genomics, immunology, and clinical outcomes to improve long-term transplant success. Her recent publications (2023–2025) emphasize noninvasive diagnostics using urinary biomarkers, consensus development in antibody-mediated rejection (Banff Working Group), kidney paired donation trends, and integration of palliative care in transplant failure. These works span high-impact journals including Nature Medicine , American Journal of Transplantation , and Transplantation , reflecting a strong translational and clinical research trajectory. Elected Fellow, American Society of Transplantation (2015) President, New York Society of Nephrology (2014–2015) Chair, Kidney Pancreas Community of Practice, American Society of Transplantation (2017–2019) Co-Chair, Consensus Conferences on Frailty, Cardiovascular Disease, and Heart-Kidney Transplantation Editorial Board, Nephrology, Dialysis and Transplantation and Transplantation Recipient of multiple investigator awards and leadership recognitions since 2003 Dr. Dadhania has served as site Principal Investigator for NIH-supported CTOT-03 and CTOT-04 trials and currently leads multiple studies including the APOLLO Consortium and metagenomic profiling of urinary cell-free DNA. She mentors fellows through her fellowship directorship and contributes to national policy via consensus guidelines and editorial leadership. Her work bridges clinical care, research innovation, and education in transplant nephrology. She leads the Genomics Division and Immunogenetics and Transplantation Center, where her team develops and validates molecular assays for allograft monitoring. Her lab collaborates extensively with biopharma partners and national consortia to translate biomarkers into clinical practice.

Soner DoğanView profile

Professor

• Breast Cancer
• Calorie Restriction
• Molecular Biology
• +3 more

Prof. Soner Doğan is a Professor at Yeditepe University's Faculty of Medicine, Department of Medical Biology. He holds a PhD in Medical Biology from the University of Minnesota and a Bachelor's in Veterinary Science from Ankara University. His research bridges oncology, epigenetics, and metabolic regulation, with a focus on breast cancer mechanisms and calorie restriction. Research interests span: Breast Cancer Pathobiology : Investigating leptin/adiponectin signaling and epigenetic modifications in tumor development. Calorie Restriction : Examining intermittent vs. chronic dietary interventions for cancer prevention and aging. Aging and Frailty : Identifying biomarkers and molecular pathways in age-related diseases using murine models. His publications emphasize molecular oncology, with recurring themes in adipokine signaling, DNA methylation, and transcriptomic profiling. Articles frequently utilize transgenic mouse models and RNA-seq to explore metabolic and immune interactions in cancer. Awards & Honors: Professional Development Grant, Education Minnesota Foundation AICR Scholarship for Cancer Research Conference Advising & Grants : Supervised 11+ Master's/PhD theses on topics like nanoparticle drug delivery and epigenetic regulation. Secured major grants including TÜBİTAK 1001 (€395K) for breast cancer epigenetics and COST Action CA17129 for cardiovascular transcriptomics. Affiliations : Leads projects at Yeditepe’s molecular biology labs and collaborates internationally (e.g., EU-CardioRNA COST Action). Holds administrative roles as Department Coordinator and Ethics Committee member.

Christopher HoweView profile

Professor

• Photosynthesis
• Evolution of Photosynthetic Systems
• Biotechnology
• +6 more

Professor Christopher Howe is a Professor of Plant and Microbial Biochemistry at the Department of Biochemistry, University of Cambridge . He has been a Fellow of the College since 1983 and currently serves as its President . He directs studies in Preclinical Medicine , teaching Biochemistry to first-year medical students. Research Interests : Photosynthesis biochemistry and evolution Biotechnological applications of photosynthetic organisms (e.g., algae for electricity production) Plasmodium's photosynthetic ancestry and remnant chloroplast Evolutionary analysis of non-biological systems like manuscripts Coral bleaching and dinoflagellate-coral symbiosis Article Trends : Focus on cyanobacteria, dinoflagellates, and Plasmodium Biophotovoltaic systems and sustainable energy Phylogenetic methods in biological and cultural evolution Scientific Awards : Fellow of the American Academy of Microbiology (2017) Advising and Collaborations : Supervises graduate students in the Howe Group Collaborates with academic and commercial partners (Anaero Technology, LEITAT, Spireat) Labs & Teams : Leads the Howe Group at the Department of Biochemistry Co-leads the BEST Project for biophotovoltaic systems Works with 3D organotypic cultures and biophotoelectrochemistry

Robert NordonView profile

Associate Professor

• Biomedical Engineering
• Advanced Manufacturing
• Medical Technologies
• +5 more

Associate Professor Robert Nordon is a faculty member at UNSW Sydney's Graduate School of Biomedical Engineering. He holds an MB BS, BMedSci, and PhD, with research focusing on advanced manufacturing and medical technologies. Since 2016, he has secured over $5M in research grants for projects in point-of-care diagnostics, cell/gene therapy manufacturing, and stem cell science. Research interests span three primary domains: Developing microfluidic single-use disposables for scalable clinical cell production Modeling cardiovascular development using stem cell-based microfluidic systems Creating computational tools for single-cell analysis and lineage tracking His publications (2017-2024) demonstrate strong emphasis on microfluidic device engineering, stem cell dynamics, and biomaterials development. Recurring themes include hematopoietic stem cell expansion, cardiac cell behavior, and peptide-based biomaterials. Significant grants include: ARC Linkage Grant LP160100570: Scaling microfluidics for cell manufacture (2016-2019) ARC Linkage Grant LP160100573: 3D microstructures for medical devices (2016-2019) ARC Linkage Grant LP190100029: Electrophoretic cell sorters (2020-2023) CRC-P: Microbioreactor for affordable cell/gene therapy (2021-2023) Current research trainees include Farzaneh Ziaee and Eric Du.

• Genomics
• Non-coding RNA research
• Phenotype-genotype relationships
• +7 more

Professor Marcel Dinger is a prominent academic and researcher currently serving as Professor and Head of School for Biotechnology and Biomolecular Sciences at UNSW Sydney. With over 20 years of experience in genomics, he has established himself as a leading figure in both academic and entrepreneurial spheres within the field. He has published 153 papers with over 24,000 citations and maintains an h-index of 61 on Google Scholar. His leadership extends beyond academia as he serves as President of the Australasian Genomics Technologies Association (AGTA) and holds director positions at Pryzm Health and the National Centre for Indigenous Genomics (NCIG). Professor Dinger's research laboratory focuses on establishing new links between phenotype and genotype, particularly examining rare and complex diseases in relation to underexplored regions of the genome including pseudogenes, repetitive elements, non-canonical DNA structures, and noncoding RNAs. His work harnesses population-scale genomic datasets and sophisticated data science methods to bring an objective perspective to understanding how the genome stores information and how it is transacted in biology. His research interests span genomics, non-coding RNA biology, clinical applications of genomic medicine, and the development of computational approaches for analyzing complex genomic data. Analysis of Professor Dinger's recent publications reveals a strong emphasis on non-coding RNA research, particularly long noncoding RNAs and their roles in disease mechanisms. His work spans cancer genomics, neurological disorders, and fundamental genomic mechanisms including DNA secondary structures like i-motifs and G-quadruplexes. His research combines experimental approaches with advanced bioinformatics to address fundamental questions in genomic medicine and has significant translational implications for disease diagnosis and treatment. Highly Cited Researcher in Cross-Field category (2019, 2020, 2021) Fellow of the Faculty of Science (Research), Royal Society of Pathologists of Australasia (2016) NHMRC Career Development Award (2010) Queensland Government Smart Futures Fellowship (2009) Foundation of Research, Science and Technology New Zealand Postdoctoral Fellowship (2005) Professor Dinger has been instrumental in establishing and leading several significant research initiatives including Genome.One, one of the first companies globally to provide clinical whole genome sequencing services, and the Kinghorn Centre for Clinical Genomics at the Garvan Institute of Medical Research. His entrepreneurial experience includes founding four biotechnology and IT startups. He serves on multiple governance boards including the National Centre for Indigenous Genomics, focusing on using genomics to improve health outcomes for Australia's First Peoples. His laboratory at UNSW continues to advance our understanding of genomic regulation and its implications for human health and disease.